JLJanin Lautenschläger

Janin Lautenschläger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Janin Lautenschläger has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dual effect of α-synuclein disease variants on condensate formation

    by Aswathy Chandran, Aishwarya Agarwal, Tianhao Wang, Leslie Amaral, Shiyue Chen, Susana R. Chaves, Tiago F. Outeiro, Janin Lautenschläger

    α-synuclein is a pre-synaptic protein implicated in synucleinopathies including Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies, where it accumulates in intracellular aggregates termed Lewy bodies and Lewy neurites. Recent studies have reported that α-synuclein undergoes phase separation to form biomolecular condensates both in vitro and in mammalian cells. α-synuclein condensates are thought to contribute to disease through progressive aggregation. Here we show that specific PD-associated α-synuclein variants fail to form biomolecular condensates. We demonstrate that only two α-synuclein variants associated with disease, E46K and E83Q, enhance condensate formation. While other α-synuclein disease variants including A30G, G51D, and A53E fail to form condensates in cells. In iPSC-derived neurons, the extent of synaptic enrichment of different α-synuclein variants is linked to their propensity to undergo VAMP2-mediated phase separation. Our results emphasize that α-synuclein dysfunction may follow divergent pathways, with both increased and decreased condensate formation.

  • Open Access

    Dual effect of α-synuclein disease variants on condensate formation

    by Aswathy Chandran, Aishwarya Agarwal, Tianhao Wang, Leslie Amaral, Susana R. Chaves, Tiago F. Outeiro, Janin Lautenschläger

    SUMMARY: α-synuclein is a pre-synaptic protein 1,2 implicated in synucleinopathies like Parkinson’s disease and Dementia with Lewy Bodies, where it accumulates in intracellular aggregates termed Lewy bodies and Lewy neurites 3 . Recent studies have reported that α-synuclein undergoes phase separation to form biomolecular condensates both in vitro and in mammalian cells 4–7 . α-synuclein condensates are thought to contribute to disease through progressive aggregation 5,8,9 . Here we show that specific PD-associated α-synuclein variants fail to form biomolecular condensates. We demonstrate that only two α-synuclein variants associated with familial disease, E46K and E83Q, enhance condensate formation in vitro and in cells. However, variants including A30G, G51D, and A53E fail to form or have reduced levels of condensate formation in cells. The same phenotypes are reflected in the budding yeast model showing differential inclusion formation. In iPSC-derived neurons, the propensity of α-synuclein variants to undergo VAMP2-mediated phase separation reflects the level of synaptic enrichment. We show that the intrinsic propensity of α-synuclein to form condensates and the ability to bind lipid membranes are important to mediate condensate formation in cells. Our results emphasize that α-synuclein pathology follows divergent pathways, with both increased and decreased condensate formation contributing to disease. This study establishes biomolecular condensates as a key intermediate in α-synuclein dysfunction, providing a novel foundation for translational research.


  • Open Access

    VAMP2 regulates phase separation of α-synuclein

    by Aishwarya Agarwal, Aswathy Chandran, Farheen Raza, Irina-Maria Ungureanu, Christine Hilcenko, Katherine Stott, Nicholas A. Bright, Nobuhiro Morone, Alan J. Warren, Janin Lautenschläger

    α-Synuclein (αSYN), a pivotal synaptic protein implicated in synucleinopathies such as Parkinson’s disease and Lewy body dementia, undergoes protein phase separation. We reveal that vesicle-associated membrane protein 2 (VAMP2) orchestrates αSYN phase separation both in vitro and in cells. Electrostatic interactions, specifically mediated by VAMP2 via its juxtamembrane domain and the αSYN C-terminal region, drive phase separation. Condensate formation is specific for R-SNARE VAMP2 and dependent on αSYN lipid membrane binding. Our results delineate a regulatory mechanism for αSYN phase separation in cells. Furthermore, we show that αSYN condensates sequester vesicles and attract complexin-1 and -2, thus supporting a role in synaptic physiology and pathophysiology.


  • Open Access

    VAMP2 regulates phase separation of alpha-synuclein

    by Aishwarya Agarwal, Farheen Raza, Christine Hilcenko, Katherine Stott, Nobuhiro Morone, Alan J. Warren, Janin Lautenschlaeger

    Summary: Alpha-synuclein (aSYN) is a small synaptic protein that is linked to Parkinson’s disease (PD) and other synucleinopathies. aSYN has been shown to undergo protein phase separation. We found that aSYN phase separation, in vitro and in cells, is regulated by vesicle-associated membrane protein 2 (VAMP2), the vesicular SNARE protein. We show that aSYN phase separation is promoted by C-terminal electrostatic interaction, which in cells is mediated via interaction with VAMP2. The condensate formation is specific for the R-SNARE VAMP2 and critically dependent on aSYN’s capacity to bind to lipid membranes. In vitro, the addition of VAMP2 decreases the saturation concentration of aSYN phase separation, which is mediated by its juxtamembrane domain. Our results delineate a molecular mechanism for the regulation of aSYN phase separation, indicating a potential switch from the dispersed to the phase-separated state during vesicle cycling. Highlights: Alpha-synuclein phase separation is regulated by electrostatic interactions VAMP2 initiates alpha-synuclein condensation in cells Positive charges within the juxtamembrane domain of VAMP2 initiate alpha-synuclein phase separation in vitro Alpha-synuclein condensates nucleate on lipid membranes and assemble vesicular structures in cells


  • Open Access

    Protein phase separation hotspots at the presynapse

    by Janin Lautenschläger

    Fundamental discoveries have shaped our molecular understanding of presynaptic processes, such as neurotransmitter release, active zone organization and mechanisms of synaptic vesicle (SV) recycling. However, certain regulatory steps still remain incompletely understood. Protein liquid–liquid phase separation (LLPS) and its role in SV clustering and active zone regulation now introduce a new perception of how the presynapse and its different compartments are organized. This article highlights the newly emerging concept of LLPS at the synapse, providing a systematic overview on LLPS tendencies of over 500 presynaptic proteins, spotlighting individual proteins and discussing recent progress in the field. Newly discovered LLPS systems like ELKS/liprin-alpha and Eps15/FCho are put into context, and further LLPS candidate proteins, including epsin1, dynamin, synaptojanin, complexin and rabphilin-3A, are highlighted.


  • Open Access

    Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies

    by Janin Lautenschläger, Sara Wagner-Valladolid, Amberley D. Stephens, Ana Fernández-Villegas, Colin Hockings, Ajay Mishra, James D. Manton, Marcus J. Fantham, Meng Lu, Eric J. Rees, et al.


  • Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies.

    by Janin Lautenschläger, Sara Wagner-Valladolid, Amberley D Stephens, Ana Fernández-Villegas, Colin Hockings, Ajay Mishra, James Manton, Marcus J Fantham, Meng Lu, Eric J Rees, et al.

  • Open Access

    Intra-mitochondrial proteostasis is directly coupled to alpha-synuclein and Amyloid β 1-42 pathology

    by Janin Lautenschlaeger, Sara Wagner-Valladolid, Amberley D. Stephens, Ana Fernández-Villegas, Colin Hockings, Ajay Mishra, James D. Manton, Marcus J. Fantham, Meng Lu, Eric J. Rees, et al.

    Mitochondria have long been implicated in Parkinson’s disease (PD), however, it is not clear how mitochondrial impairment and alpha-synuclein pathology are coupled. We report here that intra-mitochondrial protein homeostasis plays a major role in alpha-synuclein fibril elongation, as interference with intra-mitochondrial proteases and mitochondrial protein import significantly aggravate alpha-synuclein aggregation. In contrast, direct inhibition of mitochondrial complex I, increase in intracellular calcium concentration or formation of reactive oxygen species (ROS), all of which have been associated with mitochondrial stress, did not affect alpha-synuclein pathology. We further demonstrate that similar mechanisms are involved in Amyloid β 1-42 (Aβ42) aggregation, suggesting that mitochondria are directly capable of influencing cytosolic protein homeostasis of aggregation-prone proteins.


  • Novel computer vision algorithm for the reliable analysis of organelle morphology in whole cell 3D images — A pilot study for the quantitative evaluation of mitochondrial fragmentation in amyotrophic lateral sclerosis

    by Janin Lautenschläger, Christian Lautenschläger, Vedrana Tadic, Herbert Süße, Wolfgang Ortmann, Joachim Denzler, Andreas Stallmach, Otto W. Witte, Julian Grosskreutz